Previous 10 | Next 10 |
Dr. Reddy's ( RDY ) Q4 results : Revenues: $581M (+13.7%). More news on: Dr. Reddy's Laboratories Limited, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Dr. Reddy's (NYSE: RDY ): Q4 GAAP EPS of $0.38 beats by $0.05 . More news on: Dr. Reddy's Laboratories Limited, Earnings news and commentary, Healthcare stocks news, Read more ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of...
Source INTRODUCTION In recent years there has been a populist rush to embrace socialism by those in the US who’re politically on the hard left. Although this populist theme has gained traction with some Democrats and certainly with the media, it does not appear to be favored by ...
Teva Pharmaceutical Industries (NYSE: TEVA ) slumps 8% premarket on light volume as investors react to its role in alleged price fixing by generic drug firms. Last night, the investigative journalism show 60 Minutes aired a piece on the issue that named the company as one of th...
Dr. Reddy’s Laboratories (NYSE: RDY ) has launched Testosterone Gel 1.62%, a therapeutic equivalent generic version of AbbVie's AndroGel (testosterone gel) 1.62%. More news on: Dr. Reddy's Laboratories Limited, Healthcare stocks news, Read more ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Testosterone Gel 1.62%, a therapeutic equivalent generic version of AndroGel® (testosterone g...
NEW YORK , May 1, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City announces that it is investigating Dr. Reddy's Laboratories Ltd., (NYSE: ...
A federal appeals court has ruled in Eli Lilly's ( LLY +0.9% ) favor, upholding an October 2017 decision by the USPTO's Patent Trial and Appeal Board that its patent covering a vitamin regimen for lung cancer med Alimta (pemetrexed) is valid. More news on: Eli Lilly and Company, Novart...
Laurence Doud III, former CEO of Rochester Drug Co-Operative, was indicted yesterday by a Manhattan federal grand jury on charges of narcotics conspiracy and conspiracy to defraud the Drug Enforcement Administration (DEA) related to the distribution of "tens of millions" of opioid painkill...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2024. The information mentioned in this release is based on consolidated financial statements under International Fina...
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...